Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$254.9 - $283.59 $2,803 - $3,119
-11 Reduced 1.22%
889 $229,000
Q2 2023

Jul 19, 2023

SELL
$238.39 - $265.32 $4,767 - $5,306
-20 Reduced 2.17%
900 $237,000
Q1 2023

Apr 25, 2023

SELL
$229.71 - $259.35 $18,147 - $20,488
-79 Reduced 7.91%
920 $227,000
Q4 2022

Jan 24, 2023

SELL
$218.29 - $256.91 $8,731 - $10,276
-40 Reduced 3.85%
999 $0
Q3 2022

Nov 03, 2022

SELL
$51.03 - $264.23 $82,362 - $426,467
-1,614 Reduced 60.84%
1,039 $232,000
Q2 2022

Aug 09, 2022

BUY
$234.74 - $275.42 $420,654 - $493,552
1,792 Added 208.13%
2,653 $654,000
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $48,484 - $53,825
-199 Reduced 18.77%
861 $229,000
Q3 2021

Oct 25, 2021

SELL
$232.72 - $256.47 $15,592 - $17,183
-67 Reduced 5.94%
1,060 $260,000
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $33,268 - $36,404
-143 Reduced 11.26%
1,127 $274,000
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $62,896 - $69,614
-271 Reduced 17.59%
1,270 $309,000
Q4 2020

Feb 18, 2021

SELL
$221.92 - $245.94 $1,775 - $1,967
-8 Reduced 0.52%
1,541 $386,000
Q3 2020

Nov 23, 2020

BUY
$215.77 - $276.76 $334,227 - $428,701
1,549 New
1,549 $360,000
Q3 2020

Nov 16, 2020

SELL
$215.77 - $276.76 $367,456 - $471,322
-1,703 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $316,656 - $379,310
-1,440 Reduced 45.82%
1,703 $408,000
Q1 2020

May 05, 2020

BUY
$195.69 - $279.01 $277,097 - $395,078
1,416 Added 81.99%
3,143 $722,000
Q4 2019

May 05, 2020

BUY
$236.45 - $266.82 $408,349 - $460,798
1,727 New
1,727 $470,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.